141 related articles for article (PubMed ID: 37137466)
41. Bushen Tongluo formula ameliorated testosterone propionate-induced benign prostatic hyperplasia in rats.
Gong GY; Xi SY; Li CC; Tang WL; Fu XM; Huang YP
Phytomedicine; 2023 Nov; 120():155048. PubMed ID: 37651753
[TBL] [Abstract][Full Text] [Related]
42. Effect of Boerhaavia diffusa in experimental prostatic hyperplasia in rats.
Vyas BA; Desai NY; Patel PK; Joshi SV; Shah DR
Indian J Pharmacol; 2013; 45(3):264-9. PubMed ID: 23833370
[TBL] [Abstract][Full Text] [Related]
43. Heat-Killed and Live
Choi YJ; Fan M; Tang Y; Iwasa M; Han KI; Lee H; Hwang JY; Lee B; Kim EK
J Microbiol Biotechnol; 2021 Aug; 31(8):1134-1143. PubMed ID: 34226410
[TBL] [Abstract][Full Text] [Related]
44. Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats.
Adaramoye OA; Akanni OO; Abiola OJ; Owumi SE; Akinloye O; Olapade-Olaopa EO
Biomed Pharmacother; 2017 Nov; 95():1493-1503. PubMed ID: 28946212
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T
Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
[TBL] [Abstract][Full Text] [Related]
47. Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model.
Choi BR; Kim HK; Soni KK; Karna KK; Lee SW; So I; Park JK
Drug Des Devel Ther; 2018; 12():1855-1863. PubMed ID: 29970959
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effects of crude polysaccharides from Semen vaccariae on benign prostatic hyperplasia in mice.
Zhang H; Jing Y; Wu G
J Ethnopharmacol; 2013 Jan; 145(2):667-9. PubMed ID: 23202245
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic role of Glycyrrhiza Uralensis fisher on benign prostatic hyperplasia through 5 alpha reductase regulation and apoptosis.
Park JY; Park WY; Park J; Ahn KS; Lee JH; Kwak HJ; Um JY
Phytomedicine; 2022 Oct; 105():154371. PubMed ID: 35964456
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats.
Shin IS; Lee MY; Ha HK; Seo CS; Shin HK
BMC Complement Altern Med; 2012 Apr; 12():48. PubMed ID: 22520510
[TBL] [Abstract][Full Text] [Related]
51. Inhibitory effects of
Choi YJ; Fan M; Wedamulla NE; Tang Y; Bae SM; Hwang JY; Kim EK
Food Funct; 2022 Oct; 13(19):10235-10247. PubMed ID: 36124918
[No Abstract] [Full Text] [Related]
52. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
53. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effects of Hydrocotyle ramiflora on testosterone-induced benign prostatic hyperplasia in rats.
Park S; Hwang YH; Baek EB; Hong EJ; Won YS; Kwun HJ
Int Urol Nephrol; 2023 Jan; 55(1):17-28. PubMed ID: 36107291
[TBL] [Abstract][Full Text] [Related]
55. Chemical profiles of the active fraction from Prinsepia utilis Royle leaves and its anti-benign prostatic hyperplasia evaluation in animal models.
Peng Y; Peng C; Wu Y; Sun C; Li X
BMC Complement Med Ther; 2021 Oct; 21(1):272. PubMed ID: 34715848
[TBL] [Abstract][Full Text] [Related]
56. [Efficacy of Kangshuailing Gao on benign prostatic hyperplasia in rats].
Li R; Jia DY; Li Z; Xu DR; Luo SY
Zhonghua Nan Ke Xue; 2018 Aug; 24(8):729-734. PubMed ID: 30173434
[TBL] [Abstract][Full Text] [Related]
57. Fenofibrate mitigates testosterone induced benign prostatic hyperplasia via regulation of Akt/FOXO3a pathway and modulation of apoptosis and proliferation in rats.
Kortam MA; Alawady AS; Hamid Sadik NA; Fathy N
Arch Biochem Biophys; 2022 Jul; 723():109237. PubMed ID: 35430215
[TBL] [Abstract][Full Text] [Related]
58. Fraction of macroporous resin from Smilax china L. inhibits testosterone propionate-induced prostatic hyperplasia in castrated rats.
Chen J; Xiong CM; Song SS; Han P; Ruan JL
J Med Food; 2012 Jul; 15(7):646-50. PubMed ID: 22510101
[TBL] [Abstract][Full Text] [Related]
59. Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status.
Buncharoen W; Saenphet K; Saenphet S; Thitaram C
J Ethnopharmacol; 2016 Dec; 194():483-494. PubMed ID: 27732901
[TBL] [Abstract][Full Text] [Related]
60. Effects of Alginate Oligosaccharide on Testosterone-Induced Benign Prostatic Hyperplasia in Orchiectomized Rats.
Jang YJ; Jung HY; Myeong JY; Song KH; Kwon J; Kim D; Park JI
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
